Literature DB >> 8381406

The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin.

J Ye1, C T Esmon, A E Johnson.   

Abstract

The role of the chondroitin sulfate moiety of thrombomodulin (TM) in the binding of thrombin to TM has been examined using fluorescent derivatives of thrombin. An anilinonaphthalene-6-sulfonic acid (ANS) dye was attached covalently to the active site histidine of thrombin via a D-Phe-Pro-Arg (FPR) linkage to form ANS-FPR-thrombin. When ANS-FPR-thrombin was titrated with TM lacking the chondroitin sulfate moiety (csf-TM), a monotonic and saturable increase in ANS emission intensity was observed that was consistent with the formation of a high affinity 1:1 thrombin-csf-TM complex. In contrast, titration of ANS-FPR-thrombin with intact TM containing the chondroitin sulfate resulted in a biphasic change in ANS-FPR-thrombin emission intensity that was consistent with each molecule of TM binding at least two molecules of ANS-FPR-thrombin with different affinities. This suggested that the second thrombin binds to TM via the chondroitin sulfate moiety. A direct interaction between thrombin and chondroitin sulfate was demonstrated by showing that chondroitin sulfate, cleaved and purified from TM, caused a saturable increase in ANS emission intensity upon addition to an ANS-FPR-thrombin sample. This spectral change was reversed by adding an excess of unmodified thrombin. The minimum Kd for the ANS-FPR-thrombin-chondroitin sulfate complex was approximately 20 nM, consistent with chondroitin sulfate being the lower affinity binding site on TM for thrombin. The titration of chondroitin sulfate into ANS-FPR-thrombin samples in the absence and presence of a TM fragment containing the fifth and sixth growth factor-like domains (GF5-6) showed that GF5-6 did not block chondroitin sulfate binding and that a GF5-6-thrombin-chondroitin sulfate ternary complex was formed. Thus, the chondroitin sulfate binds to thrombin somewhere other than anion-binding exosite I, and in doing so, alters the structure and/or environment of the active site more than 15A from the active site serine without detectably changing the conformation near Ser-195. Since excess TM and excess csf-TM increased the ANS emission intensity of ANS-FPR-thrombin to different extents (approximately 15 and approximately 80%, respectively), the chondroitin sulfate also influences the environment of the active site probe even when thrombin is bound to the higher affinity site on TM (GF5-6).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis.

Authors:  Thomas J Raife; Denis M Dwyre; Jeff W Stevens; Rochelle A Erger; Lorie Leo; Katina M Wilson; Jose A Fernández; Jennifer Wilder; Hyung-Suk Kim; John H Griffin; Nobuyo Maeda; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

3.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

4.  Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.

Authors:  M Anna Kowalska; Sriram Krishnaswamy; Lubica Rauova; Li Zhai; Vincent Hayes; Karine Amirikian; Jeffrey D Esko; Daniel W Bougie; Richard H Aster; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

5.  Thrombin inhibition by cyclic peptides from thrombomodulin.

Authors:  J C Lougheed; C L Bowman; D P Meininger; E A Komives
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

6.  Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474.

Authors:  B Gerlitz; T Hassell; C J Vlahos; J F Parkinson; N U Bang; B W Grinnell
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  Inactivation of thrombomodulin by ionizing radiation in a cell-free system: possible implications for radiation responses in vascular endothelium.

Authors:  Christopher C Ross; Stewart L MacLeod; Jason R Plaxco; Jeffrey W Froude; Louis M Fink; Junru Wang; Wesley E Stites; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2008-04       Impact factor: 2.841

Review 8.  Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.

Authors:  Fiona A Martin; Ronan P Murphy; Philip M Cummins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.